| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/07/2001 | EP1073753A1 Grapevine leafroll virus proteins and their uses |
| 02/07/2001 | EP1073752A1 PROTEIN WITH THE AMINO ACID SEQUENCE OF DELTA 7 STEROL REDUCTASE,ISOLATED cDNA MOLECULE CODING FOR SAID PROTEIN, RECOMBINANT DNA VECTOR AND BIOLOGICALLY ACTIVECOMPOSITIONS CONTAINING SAID PROTEIN OR SAID cDNA MOLECULE |
| 02/07/2001 | EP1073751A2 Polypeptide with immunogenic properties and with a protein with modified biological functions |
| 02/07/2001 | EP1073750A1 Preparation of human papillomavirus e1 having helicase activity and method therefor |
| 02/07/2001 | EP1073749A2 Enhancing immune responses to genetic immunization by using a chemokine |
| 02/07/2001 | EP1073748A2 Vaccines containing recombinant pilin against neisseria gonorrhoeae or neisseria meningitidis |
| 02/07/2001 | EP1073747A1 Basb013 dna and proteins from neisseria meningitidis |
| 02/07/2001 | EP1073746A2 Bacterial yjeq polypeptide family |
| 02/07/2001 | EP1073745A2 Immunization against and treatment for infection by h. pylori |
| 02/07/2001 | EP1073744A1 Multifunctional adhesin proteins and their display in microbial cells |
| 02/07/2001 | EP1073743A1 Flowering locus t (ft) and genetically modified plants having modulated flower development |
| 02/07/2001 | EP1073742A2 Human nucleic acid sequences of bladder tumour tissue |
| 02/07/2001 | EP1073741A2 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides |
| 02/07/2001 | EP1073740A1 Polynucleotides isolated from skin cells and methods for their use |
| 02/07/2001 | EP1073739A2 Cd40-interacting and traf-interacting proteins |
| 02/07/2001 | EP1073738A2 Human k+ ion channel and therapeutic applications thereof |
| 02/07/2001 | EP1073737A2 Immunosuppression by blocking t cell co-stimulation signal 2 (b7/cd28 interaction) |
| 02/07/2001 | EP1073736A1 Delayed rectifier potassium channel subunit |
| 02/07/2001 | EP1073735A1 Host-encoded protein expressed on marek's disease virus (mdv)-infected cells and antibody thereto |
| 02/07/2001 | EP1073734A2 Tumor associated nucleic acids and uses therefor |
| 02/07/2001 | EP1073733A1 MUTATED PEPTIDE COMPOUNDS, DERIVED FROM hsp70, USEFUL IN CANCER IMMUNOTHERAPY |
| 02/07/2001 | EP1073732A2 Nucleoside triphosphates and their incorporation into ribozymes |
| 02/07/2001 | EP1073731A2 Nucleic acid enzyme for rna cleavage |
| 02/07/2001 | EP1073730A1 Use of a ribozyme to join nucleic acids and peptides |
| 02/07/2001 | EP1073729A2 Neuropilin antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 02/07/2001 | EP1073728A2 Insulin-like growth factor ii antisense oligonucleotide sequences and methods of using same to modulate cell growth |
| 02/07/2001 | EP1073727A2 Human nucleic acid sequences from ovarian tumour tissue |
| 02/07/2001 | EP1073723A2 Ste20-related protein kinases |
| 02/07/2001 | EP1073722A1 Pyruvate carboxylase overexpression for enhanced production of oxaloacetate-derived biochemicals in microbial cells |
| 02/07/2001 | EP1073719A2 Process for obtaining stem cells |
| 02/07/2001 | EP1073718A1 Nucleic acids that control seed and fruit development in plants |
| 02/07/2001 | EP1073717A1 Methods of screening for agonists and antagonists of the interaction between the human kiaa0001 receptor and ligands thereof |
| 02/07/2001 | EP1073713A1 6-phosphogluconate dehydrogenase of streptococcus pneumoniae |
| 02/07/2001 | EP1073710A2 Non-stochastic generation of genetic vaccines and enzymes |
| 02/07/2001 | EP1073707A1 A process of making a compound by forming a polymer from a template drug |
| 02/07/2001 | EP1073683A1 G-csf receptor agonist antibodies and screening method therefor |
| 02/07/2001 | EP1073682A1 Heparanase specific molecular probes and their use in research and medical applications |
| 02/07/2001 | EP1073681A1 Cloning of a novel 7tm receptor axor-2 |
| 02/07/2001 | EP1073677A1 STAPHYLOCOCCUS AUREUS pyrH POLYPEPTIDES AND POLYNUCLEOTIDES |
| 02/07/2001 | EP1073671A1 Targeted gene delivery to cells by filamentous bacteriophage |
| 02/07/2001 | EP1073670A1 Optimization of pest resistance genes using dna shuffling |
| 02/07/2001 | EP1073669A2 Gcp |
| 02/07/2001 | EP1073471A1 Method of treating endotoxemia |
| 02/07/2001 | EP1073464A1 Monoclonal antibodies with reduced immunogenicity |
| 02/07/2001 | EP1073461A1 Viral chimeras comprised of caev and hiv-1 genetic elements |
| 02/07/2001 | EP1073460A1 Nucleic acid encoding hyaluronan synthase and methods of use |
| 02/07/2001 | EP1073450A1 PNEUMOCOCCAL SURFACE PROTEIN C(PspC), EPITOPIC REGIONS AND STRAIN SELECTION THEREOF, AND USES THEREFOR |
| 02/07/2001 | EP1073442A1 Combination viral-based and gene-based therapy of tumors |
| 02/07/2001 | EP0943096A4 A PROTEIN PREPARATION THAT MEDIATES Ca2+ -DEPENDENT TRANSBILAYER MOVEMENT OF PLASMA MEMBRANE PHOSPHOLIPID AND INHIBITORS THEREOF |
| 02/07/2001 | EP0889973B1 Chain-termination type nucleic acid sequencing method including 2'-deoxyuridine-5'-triphosphate |
| 02/07/2001 | EP0830370B1 N-1-carboxyalkyl derivatives of lsd |
| 02/07/2001 | EP0754240A4 Ligase/polymerase-mediated genetic bit analysis?tm of single nucleotide polymorphisms and its use in genetic analysis |
| 02/07/2001 | EP0559769B1 Heparin binding mitogen with homology to epidermal growth factor (egf) |
| 02/07/2001 | EP0462207B1 T-pa mutants resistant to inhibition by their cognate inhibitors |
| 02/07/2001 | CN1283233A Variant loxP sequences and application of the same |
| 02/07/2001 | CN1283232A Use of novel disintegrin metalloprotease, mutants, fragments and the like |
| 02/07/2001 | CN1283231A Moldified vitamin K-dependent polypeptides |
| 02/07/2001 | CN1283230A Desaturated enzyme |
| 02/07/2001 | CN1283229A Promoter from ashbya gossypii |
| 02/07/2001 | CN1283228A Polypeptide, their production method and use |
| 02/07/2001 | CN1283227A Expression cloning in filamentous fungi |
| 02/07/2001 | CN1283225A Pectin degrading alcohol from i(Bacillus licheniformis) |
| 02/07/2001 | CN1283224A Hyaluronan synthase gene and uses thereof |
| 02/07/2001 | CN1283202A Troponic CI complexes |
| 02/07/2001 | CN1283121A HIV-ITAT or derwatives thereof for prophylatic and therapeutic vacceination |
| 02/07/2001 | CN1283120A CD8 as inhibitor of cellular immune system |
| 02/07/2001 | CN1283108A I (chlamydia) protein, gene sequence and uses thereof |
| 02/07/2001 | CN1283082A Carbohydrate oxidase and use thereof in baking |
| 02/07/2001 | CN1282791A Butyrobetaine/crotonbetaine-L-carnitine metabolic gene and its use in producing L-carnition by microbial method |
| 02/06/2001 | US6184449 1-Aminocyclopropane-1-carboxylate synthase genes from rosa to control ethylene levels in roses |
| 02/06/2001 | US6184443 Cold-inducible and tuber-specific promoter sequence from potato α-amylase gene |
| 02/06/2001 | US6184440 Transgenic plants of altered morphology |
| 02/06/2001 | US6184439 Antisense gene systems of pollination control for hybrid seed production |
| 02/06/2001 | US6184438 Mutant genes encoding plant ADP-glucose pyrophosphorylase and methods of use |
| 02/06/2001 | US6184437 Nucleotide sequences which code a polypeptide with an amino acid sequence high in lysine; for the amplification of nutritional quality of plants |
| 02/06/2001 | US6184436 Transgenic mice expressing HIV-1 in immune cells |
| 02/06/2001 | US6184435 Transgenic mouse expressing APP770-V717F |
| 02/06/2001 | US6184372 Preferential nucleotide sequences for the reduction of expression of messenger ribonucleic acid sequences; for treatment of leukemia and aquired inmmunodeficiency syndrome |
| 02/06/2001 | US6184371 Lactoferrin receptor genes of Moraxella |
| 02/06/2001 | US6184370 Polypeptide receptor segment; for the design of agonists and antagonists to growth factor and cytokine activities |
| 02/06/2001 | US6184369 Anti-viral guanosine-rich oligonucleotides |
| 02/06/2001 | US6184364 Dehydrating uridine to form 2,2'-anhydrouridine, converting to unprotected 2'-azido-2'-deoxyuridine, iodinating to form 5-iodo-2'-azido, 2'-deoxyuridine, then reducing to 5-iodo, 2'-amino-2'-deoxyuridine; selex ligands |
| 02/06/2001 | US6184359 Humanized monoclonal antibody which preferentially binds lymphocyte polypeptide; for treatment of toxicity in tumor therapy; for the treatment and prevention of gastrointestinal and viral diseases |
| 02/06/2001 | US6184358 IP-10/Mig receptor designated CXCR3, antibodies, nucleic acids, and methods of use therefor |
| 02/06/2001 | US6184357 Antibody which binds a preferential polypeptide; for the diagnosis, prevention and treatment of prostate cancer and hyperplasia |
| 02/06/2001 | US6184356 Globin protein; for amplifying oxygen carrying capacity of a blood substitute |
| 02/06/2001 | US6184355 FAE1 genes and their uses |
| 02/06/2001 | US6184354 Peptides of human macrophage colony stimulating factor binding protein; for the detection of modulators of macrophage colony stimulating factor |
| 02/06/2001 | US6184353 Method for modulating processes mediated by farnesoid activated receptors |
| 02/06/2001 | US6184352 Adseverin protein |
| 02/06/2001 | US6184351 Artificial brain protein; for the treatment of alzheimer's and parkinson's disease |
| 02/06/2001 | US6184349 Cloned peripheral nerve, tetrodotoxin-resistant sodium channel α-subunit |
| 02/06/2001 | US6184348 Genetically engineered amino acid sequences which represent duplicated oligopeptides; for the biosynthesis of preferential polypeptides |
| 02/06/2001 | US6184256 Methods and compositions for use in modulating expression of matrix metalloproteinase genes |
| 02/06/2001 | US6184212 Antisense modulation of human mdm2 expression |
| 02/06/2001 | US6184211 Inhibition of DNA methyltransferase |
| 02/06/2001 | US6184205 Purified peptide of given amino acid sequences that binds to the n-terminal sh3 domain of grb2; useful in modulating signal transduction pathways at the cellular level, in modulating oncogenic protein activity |
| 02/06/2001 | US6184202 Modulating apoptosis of a cell by administering an agent comprising a bh1 or bh2 domain capable of promoting or inhibiting formation of a complex of bcl-2:blc-2; bcl-xl:bcl-xl; bax:bax; and/or bcl-xl:bax |
| 02/06/2001 | US6184200 Truncated glial cell line-derived neurotrophic factor |
| 02/06/2001 | US6184038 Transport proteins and their uses |